Skip to content

Virtual reality rehabilitation findings in multiple sclerosis depend on the outcome

A review summary reported balance advantages over conventional therapy, with no significant differences for gait, cognition or fatigue.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The summary reports better balance and postural control with virtual reality than with conventional therapy. It found no statistically significant differences for gait, cognitive function or fatigue in that comparison. Benefits reported against no intervention concerned upper-limb function and quality of life, making the comparison group essential to understanding the findings.

Keep in mind

This record is a summary with commentary on another review. Its abstract gives no numerical effect estimates, follow-up durations or detailed certainty assessments, and the authors describe the evidence as insufficiently clear.

THE RESULT, WITH CONTEXT

What researchers found

Reported improvement

Balance and postural control

Virtual reality versus conventional therapy in adults with multiple sclerosis; effect scale and assessment timeframe were not reported in the abstract.

NeuroRehabilitation, 2025 · Original source ↓

Comparisons answer different questions

An advantage over no intervention does not establish an advantage over conventional rehabilitation. Keeping these comparisons separate avoids attributing the reported upper-limb and quality-of-life findings to a head-to-head comparison that the abstract does not describe.

A varied rehabilitation tool

The reviewed programs included immersive and non-immersive virtual reality and targeted different abilities. This variation, together with mixed outcome findings, limits any claim that virtual reality is broadly superior across multiple sclerosis rehabilitation.

CHECK THE ORIGINAL

The original publication

Are Virtual Reality Interventions Effective in Improving Outcomes in People with Multiple Sclerosis? A Cochrane Review Summary with Commentary.

Amatya B, Khan F
NeuroRehabilitation · 2025

PubMed ID
40905746
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.